Please find enclosed herewith with respect to Board Meeting update

Date: 02nd September, 2026 Corporate Relations Department BSE Limited 25th Floor, P J Towers, Dalal Street, Fort, Mumbai – 400 001 Scrip Code: 544694 Dear Sir/ Madam, Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Reference: 1. Corporate Announcement filed with BSE on 01st September, 2026 under Regulation 30 of the SEBI (LODR) Regulations, 2015. 2. In response to the email received from BSE Limited on 02nd September, 2026 regarding Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 1st September, 2026 has, inter-alia, following businesses: 1. Approved the proposal of alteration of Object Clause (Clause III) in the Memorandum of Association of the Company, the brief details of the proposed alteration are set out in Annexure – A attached hereto, as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January, 2026. 2. Approved the proposal for increasing the borrowing limits under section 180(1)(c) of the Companies Act, 2013 and rule made thereunder with respect to raising loans, borrowings, issuing debt securities or debt instruments and such other permissible securities by way of private placement, public issue or other permissible mode, in one or more tranches and in accordance with the applicable laws, subject to the receipt of the necessary approvals, including approval of the shareholders of the Company and other regulatory / statutory approvals, as may be required. 3. Approved the proposal for enhancement of the limit under Section 180(1)(a) of the Companies Act, 2013 with respect to creation of charge, mortgage, hypothecation or other security on the Company's movable and immovable properties in favour of banks, financial institutions, lenders and other security holders, as may be required from time to time. 4. Approved the proposal for advancing loans or providing guarantees/security to entities in which directors may be interested as deemed beneficial and in the best interest of the Company under Section 185 of the Companies Act, 2013. 5. Approved the proposal for granting loans, guarantees, and investments exceeding prescribed limits under Section 186 of the Companies Act, 2013. The said approvals are subject to approval of Shareholders through postal ballot process and applicable provisions of the Companies Act, 2013 including SEBI (Listing Obligations and 27, Xcelon Industrial Park-1, Vasna-Chacharwadi, Ta-Sanand, Ahmedabad 382 213, Gujarat, INDIA Contact: 079-45906329 Email: info@accretionnutraveda.com Website: www.accretionnutraveda.com CIN: L24290GJ2021PLC121216 Disclosure Requirements) Regulations 2015. Copy of the Postal Ballot Notice will be filed with the stock exchanges and would also be made available on our website www.accretionnutraveda.com in due course of time. The Board Meeting commenced at 11:00 AM and concluded at 12:10 PM. You are requested to kindly take on your record. Thanking You. Yours truly, For Accretion Nutraveda Limited [Formerly Known as Accretion Nutraveda Private Limited] CS Payal Kotadiya Company Secretary and Compliance Officer Encl: as above 27, Xcelon Industrial Park-1, Vasna-Chacharwadi, Ta-Sanand, Ahmedabad 382 213, Gujarat, INDIA Contact: 079-45906329 Email: info@accretionnutraveda.com Website: www.accretionnutraveda.com CIN: L24290GJ2021PLC121216 ANNEXURE – A BRIEF DETAILS OF THE PROPOSED ALTERATION TO THE MEMORANDUM OF ASSOCIATION (“MOA”) OF THE COMPANY: The Board of Directors of the Company, at its meeting held on 1st September, 2026, has approved the proposal for alteration of the Object Clause – III of the Memorandum of Association (“MOA”) of the Company, subject to the approval of the members of the Company and such other approvals as may be required under applicable laws. The proposed alteration involves insertion and/or substitution of certain objects in the Main Object Clause – III(A) of the MOA of the Company and the insertion of new sub-clauses numbered Clause III(B)(58) to Clause III(B)(69) after the existing Clause III(B)(57). Accordingly, the existing Object Clause – III of the MOA is proposed to be altered and amended by inserting and/or substituting the Main Object Clause – III (A) and inserting new sub- clauses under Clause III(B), numbered Clause III(B)(58) to Clause III(B)(69). Consequently, the revised Object Clause – III of the MOA shall read as under: A. THE MAIN OBJECTS TO BE PURSUED BY THE COMPANY ON ITS INCORPORATION ARE: 1. To carry on in India or anywhere in the world the business of manufacturing, producing, processing, formulating, developing, researching, testing, refining, mixing, fabricating, assembling, growing, buying, selling, purchasing, importing, exporting, trading (online or offline), distributing, marketing, stocking, registering, packing, repacking, preserving and otherwise dealing, either directly or through manufacturers, producers, processors, makers, fabricators, growers, refiners, buyers, sellers, importers, exporters, distributors, inventors, converters, traders, retailers, wholesalers, suppliers, chemists, druggists, indenters, packers, movers, stockists, agents, sub-agents, merchants, jobbers, brokers, consignment agents, handling agents or consultants, in all kinds of Nutraceuticals, dietary supplements, vitamins, Ayurvedic, Homeopathic, Unani, Allopathic, Naturecure, Herbal, Wellness, organic compounds, fermentation products, drugs, pharmaceuticals, medicaments, bulk drugs, intermediates, raw materials, acids, alkalis, medicines, injections, injectable preparations, parenteral preparations, sterile preparations, intravenous and intramuscular preparations, chemical contraceptives, antibodies, manure and Veterinary products, and all pharmaceutical, medicinal, healthcare and allied products for human beings, birds, animals, insects or other purposes; cosmetics, medicated soaps, shampoos, toiletries, scents, lotions, creams, globules, mother tincture preparations and personal hygiene products; surgical, medical, dental and scientific equipment and devices, diagnostic kits and reagents, diagnostic equipment, healthcare aids, accessories and instruments, anatomical, orthopaedic and surgical instruments, implants, package containers and bottles, bandages, medical cotton, gauze, crutches and apparatus; and to undertake related activities including distribution, wholesale, retail, supply, marketing, registration, packing, repacking, stocking, consignment and handling agency, consultancy, research and development, and to run hospitals and diagnostic centres, and generally to deal in all products, goods, materials, equipment, instruments and articles connected with or incidental to the pharmaceutical, drugs, medicaments, surgical, medical, diagnostic, cosmetic, healthcare and allied industries. 27, Xcelon Industrial Park-1, Vasna-Chacharwadi, Ta-Sanand, Ahmedabad 382 213, Gujarat, INDIA Contact: 079-45906329 Email: info@accretionnutraveda.com Website: www.accretionnutraveda.com CIN: L24290GJ2021PLC121216 2. To establish, develop, set up, run, maintain and operate in India or anywhere in the world chemists and druggists shops, dispensaries, hospitals, nursing homes, maternity homes, child welfare and family planning centres, diagnostic centres, mobile medical service centres, medical camps, pathology and clinical testing laboratories, radiology, X-Ray and ECG clinics, medical institutes, medical colleges, training colleges and other institutions, and to establish and operate factories, laboratories, commercial test houses, research and development centres, formulation development depar [Showing first 8,000 characters — download PDF for full document]